17 Sep 2025 | 3 Mins Read
Dr Reddy's launches acid blocker Tegoprazan in India
Flipitmoney
Dr. Reddy's Laboratories launched Tegoprazan, a potassium-competitive acid blocker (PCAB), in India under the brand name PCAB. The drug treats acid-related disorders such as erosive GERD and gastric ulcers with faster onset and longer pH control. It is already approved in 21 countries and has completed Phase III trials in the US.